Is there a relationship between fibromyalgia and rhinitis?

Allergy and Asthma Proceedings

Volumn 33, Issue 6, 2012, Pages 443-449

  Frieri, Marianne ^a   Argyriou, Antigone ^b  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLOBENZAPRINE; CYTOKINE; DULOXETINE; GABAPENTIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; IPRATROPIUM BROMIDE; L SELECTIN; MILNACIPRAN; NALTREXONE; NERVE GROWTH FACTOR; NEUROPEPTIDE; PLACEBO; PREGABALIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC RHINITIS; ALLERGY TEST; ANTICHOLINERGIC SYNDROME; ANXIETY; ARTICLE; ATOPY; CHRONIC FATIGUE SYNDROME; CYSTIC FIBROSIS; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EXERCISE; FIBROMYALGIA; GLIA; HUMAN; IMMUNOREGULATION; INJURY; MIGRAINE; NEUROTROPISM; PANIC; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; QUALITY OF LIFE; RHINITIS; SIGNAL TRANSDUCTION; SINUSITIS; SKIN TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; VASOMOTOR RHINITIS; VIRUS INFECTION;

ANIMALS; FIBROMYALGIA; HUMANS; MUSCULOSKELETAL PAIN; RHINITIS;

EID: 84871688327     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3596     Document Type: Article

References (48)

1. Abeles AM, Pillinger MH, Solitar BM, et al. Narrative review: The pathophysiology of fibromyalgia. Ann Intern Med 146:726-734, 2007. (Pubitemid 351640000)
2. American College of Rheumatology. Criteria for rheumatic diseases. www.rheumatology.org/practice/clinical/classification/index.asp; accessed March 30, 2010.
3. Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci 315:346-350, 1998. (Pubitemid 28285128)
4. Bengtsson A, Henriksson KG, and Larsson J. Reduced highenergy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 29:817-821, 1986. (Pubitemid 16072878)
5. Watkins LR, Milligan ED, and Maier SF. Spinal cord glia: New players in pain. Pain 93:201-205, 2001. (Pubitemid 32763176)
6. Watkins LR, Milligan ED, and Maier SF. Glial activation: A driving force for pathological pain. Trends Neurosci 24:450-455, 2001. (Pubitemid 32695356)
7. Watkins LR, and Maier SF. The pain of being sick: Implications of immune-to brain communication for understanding pain. Annu Rev Psychol 51:29-57, 2000.
8. Watkins LR, and Maier SF. Immune regulation of central nervous system functions: From sickness responses to pathological pain. J Intern Med 257:139-155, 2005. (Pubitemid 40193964)
9. Cleveland CH Jr, Fisher RH, Brestel EP, et al. Chronic rhinitis: An underrecognized association with fibromyalgia. Allergy Proc 13:263-267,1992. (Pubitemid 23026237)
10. Bresciani M, Lalibertè F, Lalibertè MF, et al. Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis. Allergy 64:112-117, 2009.
11. Wilfong ER, and Dey RD. Nerve growth factor and substance P regulation in nasal sensory neurons after toluene diisocyanate exposure. Am J Respir Cell Mol Biol 30:793-800, 2004. (Pubitemid 38736902)
12. Martin VT, Taylor F, Gebhardt B, et al. Allergy and immunotherapy: Are they related to migraine headache? Headache 51:8-20, 2011.
13. de Tommaso M. Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches. Expert Rev Neurother 12:287-295, 2012.
14. Baraniuk JN, Clauw D, Yuta A, et al. Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/chronic fatigue syndrome subjects. Am J Rhinol 12:435-440, 1998.
15. Wang H, Buchner M, Moser MT, et al. The role of IL-8 in patients with fibromyalgia: A prospective longitudinal study of 6 months. Clin J Pain 25:1-4, 2009.
16. Jaimez L, Lai SY, Wang SF, et al. The effect of macrolide therapy on specific S. pneumoniae cytokine and nitric oxide production in patients with acute sinusitis. Ann Allergy Asthma Immunol 80:Abstract 63a, 1998.
17. Baraniuk JN. Relationships among rhinitis, fibromyalgia, and chronic fatigue. Allergy Asthma Proc 31:169-178, 2010.
18. Smith HS, et al. Neural influences on pain and sensory processing. Pain Physician 14:E217-E245, 2011.
19. Sautter NB, Mace J, Chester AC, et al. The effects of endoscopic sinus surgery on level of fatigue in patients with chronic rhinosinusitis. Am J Rhinol 22:420-426, 2008.
20. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
21. Sardana N, and Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol 29:297-306, 2011.
22. Ravindran M, and Baraniuk JN. The sinus headache explained. Curr Allergy Asthma Rep 10:202-209, 2010.
23. Arold LM, Leon T, Whalen E, and Barrett J. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia. Psychosomatics 51:489-497, 2010.
24. Buskila D, and Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep 11:333-338, 2007. (Pubitemid 47505863)
25. Häuser W, Kosseva M, Üceyler N, et al. Emotional, physical, and sexual abuse in fibromyalgia syndrome: A systematic review with meta-analysis. Arthritis Care Res (Hoboken) 63:808-820, 2011.
26. Postolache TT, Lapidus M, Sander ER, et al. Changes in allergy symptoms and depression scores are positively correlated in patients with recurrent mood disorders exposed to seasonal peaks in aeroallergens. Scientific World J 17:1968-1977, 2007.
27. Manalai P, Hamilton RG, Langenberg P, et al. Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season. Bipolar Disord 14:90-98, 2012.
28. Sequeira JF, Cesic D, Keser G, et al. Allergic disorders in systemic lupus erythematosus. Lupus 2:187-191, 1993. (Pubitemid 23225637)
29. Torrente-Segarra V, Carbonell-Abelló J, Castro-Oreiro S, and Manresa Domínguez JM. Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol 28(suppl 63):S22-S26, 2010.
30. Frieri M. Accelerated atherosclerosis in systemic lupus erythematosus. Role of proinflammatory cytokines and therapeutic approaches. Curr Allergy Asthma Rep 12:25-32, 2012.
31. Buskila D, Atzeni F, and Sarzi-Puttini P. Etiology of fibromyalgia: The possible role of infection and vaccination. Autoimmun Rev 8:41-43, 2008.
32. Luczkowiak J, Sierra O, González-Martín JJ, et al. No xenotropic murine leukemia virus-related virus detected in fibromyalgia patients. Emerg Infect Dis 17:314-315, 2011.
33. Martinez-Lavin M. Fibromyalgia: When distress becomes (un) sympathetic pain. Pain Res Treat 98:1565, 2012.
34. Solitar BM. Fibromyalgia: Knowns, unknowns, and current treatment. Bull NYU Hosp Joint Dis 68):157-161, 2010.
35. Ablin J, Buskila D, and Clauw DJ. Biomarkers in fibromyalgia. Curr Pain Headache Rep 13:343-349, 2009.
36. Coffey CS, Mulligan RM, and Schlosser RJ. Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis. Am J Rhinol Allergy 23:571-574, 2009.
37. Raap U, and Braunstahl GJ. The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr Opin Allergy Clin Immunol 10:8-13, 2010.
38. Lee YC, Nassikas NJ, and Clauw DJ. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther 13:211, 2011.
39. Bradley LA. Pathophysiology of fibromyalgia. Am J Med 122: S22-S30, 2009.
40. Cordero MD, De Miguel M, Moreno Fernández AM, et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: Implications in the pathogenesis of the disease. Arthritis Res Ther 12:R17, 2010.
41. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 37:32-40, 1994.
42. Mease PJ, Russel IJ, Arnold LM, et al. A randomized, double blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. Nat Clin Pract Rheumatol 4:514-515, 2008.
43. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: A randomized, double blind, placebo-controlled, multicenter trial. Arthritis Rheum 56:1336-1344, 2007. (Pubitemid 46608659)
44. Younger J, and Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: A pilot study. Pain Med 10:663-672, 2009.
45. Vierck CJ. A mechanism-based approach to prevention of and therapy for fibromyalgia. Pain Res Treat 2012:951354, 2012.
46. Mease PJ, Dundon K, and Sarzi-Puttini P. Pharmacotherapy of fibromyalgia. Best Pract Res Clin Rheumatol 25:285-297, 2011.
47. Centers for Disease Control and Prevention. Chronic fatigue syndrome. www.cdc.gov/cfs/diagnosis/index.html; accessed March 30, 2010.
48. Ge HY, Wang Y, Fernández-de-las-Peñas C, et al. Reproduction of overall spontaneous pain pattern by manual stimulation of active myofascial trigger points in fibromyalgia patients. Arthritis Res Ther 13:R48, 2011.